Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7777]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Using pulsed ultrasound to optimise drug delivery to brain tumours
Dr Kévin Beccaria - Hôpital Necker, Paris, France
Using pulsed ultrasound to optimise drug delivery to brain tumours ( Dr Kévin Beccaria - Hôpital Necker, Paris, France )
4 Feb 2016
Editor's choice for January 2016
Prof Gordon McVie - ecancer Editor
Editor's choice for January 2016 ( Prof Gordon McVie - ecancer Editor )
2 Feb 2016
Genome instability can be exploited for cancer therapy
Prof Steve Jackson - University of Cambridge, Cambridge, UK
Genome instability can be exploited for cancer therapy ( Prof Steve Jackson - University of Cambridge, Cambridge, UK )
29 Jan 2016
What is the impact of TOR on nuclear dynamics?
Dr Susan Gasser - Friedrich Meischer Institute, Basel, Switzerland
What is the impact of TOR on nuclear dynamics? ( Dr Susan Gasser - Friedrich Meischer Institute, Basel, Switzerland )
29 Jan 2016
What is the DNA-dependent protein kinase, DNA-PK?
Dr Susan Lees-Miller - University of Calgary, Calgary, Canada
What is the DNA-dependent protein kinase, DNA-PK? ( Dr Susan Lees-Miller - University of Calgary, Calgary, Canada )
29 Jan 2016
DNA damage response is related to cellular homeostasis
Prof Yossi Shiloh - Tel Aviv University, Tel Aviv, Israel
DNA damage response is related to cellular homeostasis ( Prof Yossi Shiloh - Tel Aviv University, Tel Aviv, Israel )
29 Jan 2016
Checkpoint machinery protects against cancer
Prof Jiri Bartek - Danish Cancer Society Research Centre, Copenhagen, Denmark
Checkpoint machinery protects against cancer ( Prof Jiri Bartek - Danish Cancer Society Research Centre, Copenhagen, Denmark )
29 Jan 2016
Connections between DNA-PK, ATM, ATR and mTOR dependent pathways
Prof Marco Foiani - Scientific director, IFOM, Milan
Connections between DNA-PK, ATM, ATR and mTOR dependent pathways ( Prof Marco Foiani - Scientific director, IFOM, Milan )
29 Jan 2016
What is the potential of TOR inhibition for cancer therapy?
Dr Mike Hall - University of Basel, Basel, Switzerland
What is the potential of TOR inhibition for cancer therapy? ( Dr Mike Hall - University of Basel, Basel, Switzerland )
29 Jan 2016
Mathematical modelling can be used in cancer therapy
Dr Arne Lindqvist - Karolinska Institutet
Mathematical modelling can be used in cancer therapy ( Dr Arne Lindqvist - Karolinska Institutet )
29 Jan 2016
Recombination can drive tumourogenesis
Prof James Haber - Brandeis University, Waltham, USA
Recombination can drive tumourogenesis ( Prof James Haber - Brandeis University, Waltham, USA )
29 Jan 2016
The role of the PI3K and TOR pathways in cancer
Dr David Fruman - University of California, Irvine, USA
The role of the PI3K and TOR pathways in cancer ( Dr David Fruman - University of California, Irvine, USA )
29 Jan 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation